Axsome Therapeutics
AXSM
#1808
Rank
NZ$20.04 B
Marketcap
NZ$389.55
Share price
-1.62%
Change (1 day)
117.37%
Change (1 year)

Market capitalization of Axsome Therapeutics (AXSM)

Market cap: NZ$20.04 Billion

As of May 2026 Axsome Therapeutics has a market cap of NZ$20.04 Billion. This makes Axsome Therapeutics the world's 1808th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Axsome Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.04 B51.46%
2025NZ$13.23 B77.65%
2024NZ$7.45 B25.1%
2023NZ$5.95 B12.89%
2022NZ$5.27 B153.05%
2021NZ$2.08 B-50.56%
2020NZ$4.21 B-25.61%
2019NZ$5.66 B4381.16%
2018NZ$0.12 B-36.98%
2017NZ$0.20 B7.54%
2016NZ$0.18 B-28.04%
2015NZ$0.25 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of Axsome Therapeutics was reported to be:

NZ$20.37 Billion
by Nasdaq info icon info icon
NZ$20.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.46 B-92.71%๐Ÿ‡บ๐Ÿ‡ธ USA